JAK2 Mutation in Patients with Splanchnic Venous Thrombosis: a Pilot Study from India

Overview

Journal Indian J Med Res

Specialty General Medicine

Date 2012 May 8

PMID 22561633

Citations 4

Authors

S Sazawal

S Rathi

S Chikkara

R Chaubey

T Seth

A Saraya

J Das

M Mahapatra

R Saxena

Affiliations

Soon will be listed here.

Citing Articles

Prothrombotic states in portal vein thrombosis and Budd-Chiari syndrome in India: A systematic review and meta-analysis.

Giri S, Angadi S, Varghese J, Sundaram S, Bhrugumalla S Indian J Gastroenterol. 2023; 42(5):629-641.

PMID: 37610562 DOI: 10.1007/s12664-023-01400-5.

JAK2V617F Mutation in Patient with Splanchnic Vein Thrombosis.

Kumar N, Sharma S, Binota J, Ahluwalia J, Varma N, Naseem S Indian J Hematol Blood Transfus. 2020; 36(4):700-704.

PMID: 33100713 PMC: 7573011. DOI: 10.1007/s12288-020-01292-x.

Low frequency of V617F mutation in JAK2 gene in Indian patients with hepatic venous outflow obstruction and extrahepatic portal venous obstruction.

Rai P, Kumar P, Mishra S, Aggarwal R Indian J Gastroenterol. 2016; 35(5):366-371.

PMID: 27633031 DOI: 10.1007/s12664-016-0691-7.

JAK2V617F: Is It Sufficient as a Single Player in Splanchnic Venous Thrombosis?.

Dhiman P, Saxena P Case Rep Hematol. 2015; 2015:373490.

PMID: 25878908 PMC: 4387965. DOI: 10.1155/2015/373490.

References

Baxter E, Scott L, Campbell P, East C, Fourouclas N, Swanton S . Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet. 2005; 365(9464):1054-61. DOI: 10.1016/S0140-6736(05)71142-9. View

Brodmann S, Passweg J, Gratwohl A, Tichelli A, Skoda R . Myeloproliferative disorders: complications, survival and causes of death. Ann Hematol. 2000; 79(6):312-8. DOI: 10.1007/s002779900136. View

Janssen H, Garcia-Pagan J, Elias E, Mentha G, Hadengue A, Valla D . Budd-Chiari syndrome: a review by an expert panel. J Hepatol. 2003; 38(3):364-71. DOI: 10.1016/s0168-8278(02)00434-8. View

Colaizzo D, Amitrano L, Tiscia G, Scenna G, Grandone E, Guardascione M . The JAK2 V617F mutation frequently occurs in patients with portal and mesenteric venous thrombosis. J Thromb Haemost. 2006; 5(1):55-61. DOI: 10.1111/j.1538-7836.2006.02277.x. View

Dentali F, Squizzato A, Brivio L, Appio L, Campiotti L, Crowther M . JAK2V617F mutation for the early diagnosis of Ph- myeloproliferative neoplasms in patients with venous thromboembolism: a meta-analysis. Blood. 2009; 113(22):5617-23. DOI: 10.1182/blood-2008-12-196014. View